Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
Qvar 50 Aerosol 50 micrograms per actuation pressurised inhalation solution.
| Pharmaceutical Form |
|---|
|
Pressurised inhalation, solution. A colourless solution in a pressurised aluminium canister fitted with a metering valve and an actuator. Qvar contains a propellant, which does not contain any chlorofluorocarbons (CFCs). |
Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Beclometasone |
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
| List of Excipients |
|---|
|
Propellant HFA-134a (Norflurane) |
Pressurised aluminium canister closed with a metering valve containing either 100 or 200 actuations.
Not all pack sizes may be marketed.
Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
PL 00289/1371
2nd November 2009
| Drug | Countries | |
|---|---|---|
| QVAR | Australia, Canada, France, Croatia, Israel, Japan, Netherlands, New Zealand, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
